SynthesisFrontiers in oncology2025
Structural racism as a leading cause of racial disparities in breast cancer quality of care outcomes: a systematic review.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Medicaid Expansion and Place-Based Disparities in Non-Small Cell Lung Cancer Diagnosis and Survival.JAMA network open · 2026Article
- Experiences of Discrimination and DNA Methylation Among Black Nulliparous Women.Journal of racial and ethnic health disparities · 2026Article
- The Current Landscape of Metastatic Breast Cancer: A Pathology Guide on Emerging Biomarkers.Cancers · 2026Review
- Surgical Recommendations for Black Women Compared to White Women With Ovarian Cancer in the US.Cureus · 2026Article
- Black and White disparity in U.S. female breast cancer mortality: a nationwide analysis, 1999-2023.Breast cancer research and treatment · 2026Article
- Medicaid Expansion and Overall Mortality Among Women With Breast Cancer.JAMA network open · 2026Article
- Lived experiences and perspectives of persons with conditions marked by autonomic dysfunction.PloS one · 2026Article
- Breast Cancer Disparities in African and African-Ancestry Populations: Genetics, Epigenetics, Structural Barriers and Technology-Enabled Solutions.British journal of biomedical science · 2026Review
- Advancing Equity in Breast Cancer Care Through Patient and Public Involvement and Engagement.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-Hispanic Black women have a disproportionately higher breast cancer mortality rate compared to non-Hispanic white women. Structural racism embedded within societal systems plays a fundamental role in perpetuating these persistent disparities. This systematic review aims to examine the relationship between structural racism and breast cancer quality of care outcomes across various racial and ethnic groups. Methods: Following the PRISMA guidelines, we conducted a systematic review of PubMed, Embase, and CINAHL for studies published until October 30, 2024, that examined the relationship between structural racism and breast cancer quality of care outcomes. We employed the Healthy People's Social Determinants of Health (SDOH) framework to identify structural racism measures within these five themes: economic stability, education access, healthcare access, neighborhood and built environment, and social and community welfare. Breast cancer quality of care outcomes were assessed using the Donabedian quality of care model which encompasses three components of quality: process measures, structural measures, and outcome measures. Results: We conducted a systematic review of 262 studies that included at least one measure of structural racism linked to a breast cancer quality of care outcome. Of these, 29 studies met the eligibility criteria for inclusion. The most frequently examined measures of structural racism were those related to residential segregation and redlining, which pertain to neighborhood and built environment SDOH domains. The predominant finding across the studies was that both residential segregation and redlining were significantly associated with adverse breast cancer outcomes. Theses outcomes included higher mortality rates, later-stage diagnoses, and suboptimal treatment. These effects exhibited variability based on race, comorbidity, and neighborhood characteristics, highlighting the complex role of structural racism in perpetuating disparities in breast cancer outcomes. Conclusion: The complex relationship between measures of structural racism and breast cancer quality of care outcomes underscores the necessity for ongoing research to understand the pathways through which structural racism impacts health outcomes. Understanding these pathways is essential for developing targeted interventions and promoting health equity in breast cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.